Expression and Function of Toll-Like Receptor 10 (TLR10) in Diffuse Large B Cell Lymphoma, Acute Myeloid Leukemia, and Glioma.
CONCLUSIONS Taken together, these results suggest that TLR10 could serve as a promising theranostic target for patients with glioma and is a potential biomarker for distinguishing PCNSL from GBM.
PMID: 32287174 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Biomedical Science | Brain Tumor | Cancer | Cancer & Oncology | Glioma | Leukemia | Lymphoma | Primary CNS Lymphoma | Research | Science | Study